Combined Oral Contraceptive (Estrogen-Progestin)
Combined Hormonal Contraceptive- Drug Class
- Combined Hormonal Contraceptive
- Mechanism of Action (MOA)
- Estrogen + progestin suppress the hypothalamic-pituitary axis (↓ FSH/LH) → no LH surge → ovulation inhibited; progestin also thickens cervical mucus and thins the endometrium.
- Black Box Warning
- Cigarette smoking increases the risk of serious cardiovascular events from combined oral contraceptives; the risk rises with age (especially over 35) and with the number of cigarettes smoked — contraindicated in women over 35 who smoke.
- Clinical Notes
- Some products are also indicated for heavy menstrual bleeding or moderate acne; PCOS is not an approved indication. Contraindicated with prior VTE, smoking over 35, and headache with focal neurologic symptoms or migraine with or without aura over 35.
- Source
- FDA label
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
Same family
Got a pharmacology lecture that covers Combined Oral Contraceptive (Estrogen-Progestin)? Turn it into flashcards and board-style questions, free. Drop it on the home page
All pharmacology